Skip to content
10-Q

Quarterly Report

HUBEI MINKANG PHARMACEUTICAL LTD.

0001354488-13-006354

← back to feed
Filed
Nov 14, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 8, 2013 52.19M sh
Stockholders Equity Q3 2013 · Sep 30, 2013 $11.6M
Stockholders Equity Q3 2013 · Dec 31, 2011 $7.53M
Current Liabilities Q3 2013 · Sep 30, 2013 $9.11M
Current Liabilities Q3 2013 · Dec 31, 2012 $9.54M
Total Liabilities Q3 2013 · Sep 30, 2013 $9.11M
Total Liabilities Q3 2013 · Dec 31, 2012 $9.54M
Current Assets Q3 2013 · Sep 30, 2013 $13.47M
Current Assets Q3 2013 · Dec 31, 2012 $13.2M
Total Assets Q3 2013 · Sep 30, 2013 $20.71M
Total Assets Q3 2013 · Dec 31, 2012 $20.49M
Net Income Q3 2013 · Dec 31, 2012 $961.12K
Net Income Q3 2013 · Sep 30, 2012 $243.2K
Net Income Q3 2013 · Sep 30, 2012 $746.44K
Capex Q3 2013 · Sep 30, 2012 $250.51K
Operating Cash Flow restated Q3 2013 · Sep 30, 2012 $1.36M
Sga Expense Q3 2013 · Sep 30, 2012 $787.13K
Sga Expense Q3 2013 · Sep 30, 2012 $2.19M
Rd Expense Q3 2013 · Sep 30, 2012 $5.75K
Rd Expense Q3 2013 · Sep 30, 2012 $35.22K
Operating Income Q3 2013 · Sep 30, 2012 $252.9K
Operating Income Q3 2013 · Sep 30, 2012 $803.75K
Gross Profit Q3 2013 · Sep 30, 2012 $1.66M
Gross Profit Q3 2013 · Sep 30, 2012 $4.61M
Revenue Q3 2013 · Sep 30, 2012 $3.34M
Revenue Q3 2013 · Sep 30, 2012 $9.13M
Cash And Equivalents Q3 2013 · Dec 31, 2011 $3.1M